Dr. Dayne Beccano-Kelly graduated from the University of Leeds in 2006 with a BSc (Hons) in Biochemistry (with Industry). In 2010, Beccano-Kelly went on to obtain a Medical Research Council Ph.D. (with Dr. Hugh Pearson and Prof. Chris Peers) investigating the relationship between stroke and Alzheimer’s disease (AD). Beccano-Kelly went on to investigate the potential neuro-protective effects of the feeding hormone leptin in AD as a postdoctoral researcher at the University of Dundee, Scotland, and then began work as a senior post-doctoral fellow at the University of British Columbia (Canada) Centre for Applied Neurogenetics (CAN) with Prof. Matthew Farrer and Ass. Prof. Austen Milnerwood. Beccano-Kelly joined Richard Wade-Martins’ group in 2015 as a Career Development Fellow in order to study “Parkinson’s disease in a dish” using human iPSCs, intending to characterize the ontology of PD and identify novel therapeutics. Most recently, Dr. Dayne Beccano-Kelly won a UKRI Future Leader Fellowship and will be starting his own research group in Cardiff in February, 2021.
